Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
Source: View publication →
In a large global prospective cohort, higher carbohydrate intake was associated with an increased risk of total mortality, whereas higher intake of total fat and its subtypes was associated with a lower risk of total mortality.
Key Findings
Study Design
Study Limitations
Clinical Significance
The PURE study fundamentally challenged decades of dietary guidelines that advocated for low-fat, high-carbohydrate diets. The findings suggest that global nutritional policies should be revised to relax restrictions on total fat and saturated fats, while emphasizing the limitation of excessive carbohydrate intake to improve overall mortality.
Historical Context
For decades, cardiovascular disease prevention strategies heavily emphasized reducing dietary fat, particularly saturated fat, largely based on ecological and observational data from high-income Western countries (such as Ancel Keys' Seven Countries Study). The PURE study was revolutionary because it incorporated populations from 18 countries across five continents—including low- and middle-income nations—capturing a much broader and more globally representative spectrum of macronutrient consumption.
Guided Discussion
High-yield insights from every perspective
How does the physiological processing of high-glycemic index carbohydrates differ from dietary fats, and why might an excess of these carbohydrates theoretically contribute to increased mortality over time?
Key Response
Students must understand macronutrient metabolism. High refined carbohydrate intake leads to chronic hyperinsulinemia, advanced glycation end products, and systemic inflammation, which drive metabolic syndrome and atherosclerosis. In contrast, dietary fats provide sustained energy without significant insulin spikes, potentially explaining the mortality signal seen in the PURE study when diets are heavily skewed toward carbohydrates.
When counseling a patient with metabolic syndrome on dietary modifications, how should the findings of the PURE study influence your recommendations regarding macronutrient distribution compared to traditional low-fat diet advice?
Key Response
Residents often default to traditional low-fat advice. The PURE study suggests that strict low-fat diets might inadvertently increase carbohydrate intake, worsening metabolic parameters. Counseling should shift toward reducing refined carbohydrates and allowing healthy fats rather than universal, strict fat restriction.
The PURE study found that higher fat intake was associated with lower total mortality but not significantly with major cardiovascular disease. How do we reconcile this discrepancy between mortality and CVD outcomes, and what does this imply for lipid-lowering therapies in preventive cardiology?
Key Response
Fellows should recognize that non-CVD mortality (e.g., infectious, respiratory) might be driven by malnutrition or frailty in lower-income countries where very high-carbohydrate diets are common due to poverty. The lack of association with major CVD challenges the strict diet-heart hypothesis but does not negate the proven value of pharmacological lipid-lowering (e.g., statins) in high-risk patients.
Given that the highest carbohydrate intake in the PURE study was primarily observed in low- and middle-income countries, how should a practitioner in a high-income setting adapt these findings without over-extrapolating the risks of moderate carbohydrate consumption?
Key Response
Attendings must contextualize epidemiological data. The highest quintile of carb intake in PURE was ~77% of energy, mostly from refined sources reflecting poverty. In wealthy nations, average intake is lower and more varied. Attendings should teach that while reducing refined carbs is universally beneficial, moderate intake of complex carbohydrates is not inherently dangerous.
Scholarly Review
Critical appraisal through the lens of expert reviewers and guideline development
What are the primary methodological limitations of using Food Frequency Questionnaires (FFQs) to assess long-term macronutrient intake across 18 diverse countries, and how might residual confounding by socioeconomic status distort the observed mortality associations?
Key Response
FFQs are prone to recall bias and cultural translation errors. Furthermore, a highly skewed carbohydrate-to-fat ratio in developing countries is a strong proxy for severe poverty, poor healthcare access, and reliance on cheap staple crops. Despite statistical adjustments, residual confounding by these socioeconomic factors could heavily skew the mortality data.
If you were reviewing the PURE manuscript, how would you evaluate the authors' handling of the poverty effect, given that extreme carbohydrate intake often surrogates for food insecurity, and what specific sensitivity analyses would you demand prior to publication?
Key Response
A rigorous editor would flag that the >70% carbohydrate diet is predominantly seen in impoverished populations. The editor would demand sensitivity analyses stratified by country income level (HIC vs. LMIC) and the exclusion of early mortality to prove the dietary composition itself, rather than malnutrition or poverty, drove the mortality outcomes.
Current AHA/ACC and WHO guidelines recommend limiting saturated fat intake to less than 10% of daily calories. Based on the PURE study findings that saturated fat is inversely associated with stroke and not associated with total CVD, should current upper limits on saturated fat be relaxed, and what level of evidence does this cohort provide?
Key Response
PURE provides large-scale, prospective observational evidence (Level B-NR) that contradicts strict saturated fat limits, suggesting harm only at extreme ends of consumption. A guideline committee must weigh this against randomized controlled trials evaluating LDL reduction. While it may not justify abolishing limits entirely, it strongly supports relaxing overly restrictive saturated fat targets and prioritizing the reduction of refined carbohydrates.
Clinical Landscape
Noteworthy Related Trials
Lyon Diet Heart Study
Tested
Mediterranean-type diet rich in alpha-linolenic acid
Population
Patients who survived a first acute myocardial infarction
Comparator
Prudent Western-type diet
Endpoint
Cardiovascular death and nonfatal acute myocardial infarction
WHI Dietary Modification Trial
Tested
Dietary modification promoting a reduction in total fat to 20 percent of calories and increased intake of vegetables, fruits, and grains
Population
Postmenopausal women aged 50 to 79 years
Comparator
Usual diet control group
Endpoint
Coronary heart disease and stroke
PREDIMED Trial
Tested
Mediterranean diet supplemented with extra-virgin olive oil or nuts
Population
Adults at high cardiovascular risk without established cardiovascular disease
Comparator
Low-fat control diet
Endpoint
Composite of acute myocardial infarction, stroke, or death from cardiovascular causes
Tailored to your role
Want this tailored to you?
Add your specialty or training stage to get role-specific takeaways and more questions.
Personalize this analysis